Back to Search Start Over

Updated survival analysis of EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab in MRI-defined high risk rectal cancer patients

Authors :
Sclafani, F.
Cunningham, D.
Tabernero, J.
Glimelius, Bengt
Cervantes, A.
Peckitt, C.
Tait, D.
Brown, G.
De Castro, D. Gonzalez
Chau, I.
Sclafani, F.
Cunningham, D.
Tabernero, J.
Glimelius, Bengt
Cervantes, A.
Peckitt, C.
Tait, D.
Brown, G.
De Castro, D. Gonzalez
Chau, I.
Publication Year :
2013

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1235056589
Document Type :
Electronic Resource

Tools

Authors Abstract Subjects Details